找到53记录 | 不满意,请使用左下搜索矩阵
排序: 相关性 发表日期 影响因子

Patients with classic Hodgkin lymphoma (cHL) that has relapsed after autologous or allogeneic tra...

期刊:Oncotarget  影响因子:5.168  发表日期: 20160315  PMID: 26848626 


Lung cancer is the main reason of cancer death worldwide. About 30% of non-small-cell lung cancer...

期刊:Curr Clin Pharmacol  影响因子:0.0  发表日期: 20170101  PMID: 27908252 


Cancer can escape the immune system through different mechanisms. One of which is the expression ...

期刊:J Oncol Pharm Pract  影响因子:0.0  发表日期: 20160101  PMID: 28597713 


BACKGROUND: The specific immune system is capable of preventing the development of tumor diseases...

期刊:Radiologe  影响因子:0.413  发表日期: 20171001  PMID: 28871357 


Background: There is increasing use of immune checkpoint blockade (ICB) across multiple cancer ty...

期刊:Front Oncol  影响因子:4.137  发表日期: 20190101  PMID: 30984622 


The immune checkpoint targeted agents, anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) ...

期刊:Curr Probl Cancer  影响因子:0.0  发表日期: 20170301  PMID: 28190531 


PURPOSE: Anti-programmed cell death receptor-1 (PD-1) antibodies have demonstrated antitumor acti...

期刊:Drug Des Devel Ther  影响因子:0.0  发表日期: 20160101  PMID: 27729774 




    相关搜索: